manhong zhou

Dr. manhong zhou


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2019 in Critical Care
Verified
Journal Article
Open access
PDF file
NZNi Zhu
Ni Zhu
QCQi Chen
Qi Chen
ZJZhixia Jiang
Zhixia Jiang
FLFutuan Liao
Futuan Liao
BKBujin Kou
Bujin Kou
MZmanhong zhou
manhong zhou
To evaluate the resuscitative effects of mechanical and manual chest compression in patients with out-of-hospital cardiac arrest (OHCA). All randomized controlled and cohort studies comparing the effects of mechanical compression and manual compression on cardiopulmonary resuscitation in OHCA patients were retrieved from the Cochrane Library, PubMed, EMBASE, and Ovid databases from the date of their establishment to January 14, 2019. The included outcomes were as follows: the return of spontaneous circulation (ROSC) rate, the rate of survival to hospital admission, the rate of survival to hospital discharge, and neurological function. After evaluating the quality of the studies and summarizing the results, RevMan5.3 software was used for the meta-analysis. In total, 15 studies (9 randomized controlled trials and 6 cohort studies) were included. The results of the meta-analysis showed that there were no significant differences in the resuscitative effects of mechanical and manual chest compression in terms of the ROSC rate, the rate of survival to hospital admission and survival to hospital discharge, and neurological function in OHCA patients (ROSC: RCT: OR = 1.12, 95% CI (0.90, 1.39), P = 0.31; cohort study: OR = 1.08, 95% CI (0.85, 1.36), P = 0.54; survival to hospital admission: RCT: OR = 0.95, 95% CI (0.75, 1.20), P = 0.64; cohort study: OR = 0.98 95% CI (0.79, 1.20), P = 0.82; survival to hospital discharge: RCT: OR = 0.87, 95% CI (0.68, 1.10), P = 0.24; cohort study: OR = 0.78, 95% CI (0.53, 1.16), P = 0.22; Cerebral Performance Category (CPC) score: RCT: OR = 0.88, 95% CI (0.64, 1.20), P = 0.41; cohort study: OR = 0.68, 95% CI (0.34, 1.37), P = 0.28). When the mechanical compression group was divided into Lucas and Autopulse subgroups, the Lucas subgroup showed no difference from the manual compression group in ROSC, survival to admission, survival to discharge, and CPC scores; the Autopulse subgroup showed no difference from the manual compression subgroup in ROSC, survival to discharge, and CPC scores. There were no significant differences in resuscitative effects between mechanical and manual chest compression in OHCA patients. To ensure the quality of CPR, we suggest that manual chest compression be applied in the early stage of CPR for OHCA patients, while mechanical compression can be used as part of advanced life support in the late stage.

30 October 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
LWLiaozhang Wu
Liaozhang Wu
YCYifang Cen
Yifang Cen
MFMenglong Feng
Menglong Feng
YZYanna Zhou
Yanna Zhou
HTHui Tang
Hui Tang
MZmanhong zhou
manhong zhou
Objective. To observe whether metformin (MET) plays a protective role in acute lung injury (ALI) induced by paraquat (PQ) poisoning in rats by activating the AMPK/NF-κB signaling pathway. Methods. PQ exposure was used to construct a rat model of ALI and a model of acute type II alveolar epithelial cell (RLE-6TN) injury, and MET intervention was performed. Rat lung tissue samples were collected to evaluate pathological changes in rat lung tissue, the oxidation index, and inflammatory factors; cell viability was detected by CCK-8 assays, and the protein expression levels of phospho-AMPK and phospho-NF-κBp65 in rat lung tissue and RLE-6TN cells were observed by Western blotting. Results. Compared with the PQ group, the MET treatment group showed significantly (1) reduced lung wet/dry ratio (W/D: 4.67±0.31 vs. 5.45±0.40, P<0.001), (2) reduced pathological changes in lung tissue, (3) decreased MDA levels (nmol/mg prot: 2.70±0.19 vs. 3.08±0.15, P<0.001) and increased SOD and GSH-Px activities (U/mg prot: 76.17±5.22 vs. 45.23±6.58, 30.40±2.84 vs. 21.00±3.20; all P<0.001) in lung tissue homogenate, (4) reduced levels of IL-1β, IL-6, and TNF-α in lung tissue homogenates (pg/mL: 47.87±5.06 vs. 66.77±6.55; 93.03±7.41 vs. 107.39±9.81; 75.73±6.08 vs. 89.12±8.94; all P<0.001), (5) increased activity of RLE-6TN cells (%: 0.69±0.09, 0.76±0.06, and 0.58±0.03 vs. 0.50±0.05; all P<0.05), (6) decreased protein levels of phospho-NF-κBp65 in lung homogenates and RLE-6TN cells (p-NF-κB/NF-κB: 0.47±0.09 vs. 0.81±0.13; 0.26±0.07 vs. 0.79±0.13; all P<0.01), and (7) upregulated protein expression of phospho-AMPK in lung homogenates and RLE-6TN cells (p-AMPK/AMPK: 0.88±0.05 vs. 0.36±0.12; 0.93±0.03 vs. 0.56±0.15; all P<0.01). After the addition of the AMPK inhibitor Compound C (Com C), the protein expression levels of phospho-AMPK and phospho-NF-κBp65 returned to baseline. Conclusion. MET can effectively alleviate ALI induced by paraquat poisoning and increase the viability of cells exposed to paraquat. The mechanism may be related to the activation of the AMPK/NF-κB pathway, downregulation of inflammatory mediators such as IL-6 and TNF-α, and upregulation of the SOD and GSH-Px oxidation index, and these effects can be inhibited by the AMPK inhibitor Com C.

28 January 2020 in Critical Care
Verified
Journal Article
Open access
PDF file
XLXueli Liao
Xueli Liao
ZZZiyu Zhou
Ziyu Zhou
MZmanhong zhou
manhong zhou
HTHui Tang
Hui Tang
MFMenglong Feng
Menglong Feng
LWLiaozhang Wu
Liaozhang Wu
Objectives: This study conducted a meta-analysis to assess the effectiveness, stability, and safety of mild therapeutic hypothermia (TH) induced by endovascular cooling (EC) and surface cooling (SC) and its effect on ICU, survival rate, and neurological function integrity in adult CA patients.Methods: We developed inclusion criteria, intervention protocols, results, and data collection. The results included outcomes during target temperature management as well as ICU stay, survival rate, and neurological functional integrity. The characteristics of the included population and each study were analyzed.Results: Four thousand nine hundred thirteen participants met the inclusion criteria. Those receiving EC had a better cooling efficiency (cooling rates MD = 0.31[0.13, 0.50],p < 0.01; induced cooling times MD = − 90.45[− 167.57, − 13.33],p = 0.02; patients achieving the target temperature RR = 1.60[1.19, 2.15],p < 0.01) and thermal stability during the maintenance phase (maintenance time MD = 2.35[1.22, 3.48],p < 0.01; temperature fluctuation MD = − 0.68[− 1.03, − 0.33],p < 0.01; overcooling RR = 0.33[0.23, 0.49],p < 0.01). There were no differences in ICU survival rate (RR = 1.22[0.98, 1.52],p = 0.07,I2 = 0%) and hospital survival rate (RR = 1.02 [0.96, 1.09],p = 0.46,I2 = 0%), but EC reduced the length of stay in ICU (MD = − 1.83[− 3.45, − 0.21],p = 0.03,I2 = 49%) and improved outcome of favorable neurological function at discharge (RR = 1.15[1.04, 1.28],p < 0.01,I2 = 0%). EC may delay the hypothermia initiation time, and there was no significant difference between the two cooling methods in the time from the start of patients’ cardiac arrest to achieve the target temperature (MD = − 46.64[− 175.86, 82.58]). EC was superior to non-ArcticSun in terms of cooling efficiency. Although there was no statistical difference in ICU survival rate, ICU length of stay, and hospitalization survival rate, in comparison to non-ArcticSun, EC improved rates of neurologically intact survival (RR = 1.16 [1.01, 1.35],p = 0.04,I2 = 0%).Conclusions: Among adult patients receiving cardiopulmonary resuscitation, although there is no significant difference between the two cooling methods in the time from the start of cardiac arrest to achieve the target temperature, the faster cooling rate and more stable cooling process in EC shorten patients’ ICU hospitalization time and help more patients obtain good neurological prognosis compared with patients receiving SC. Meanwhile, although EC has no significant difference in patient outcomes compared with ArcticSun, EC has improved rates of neurologically intact survival.

12 January 2023 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
HZHong Zhong
Hong Zhong
ZYZhaohui Yin
Zhaohui Yin
BKBojin Kou
Bojin Kou
PSPei Shen
Pei Shen
GHGuoli He
Guoli He
RDRenli Deng
Renli Deng
Objective: The efficacy and safety of epinephrine in patients with out-of-hospital cardiac arrest (OHCA) remains controversial. The meta-analysis was used to comprehensively appraise the influence of epinephrine in OHCA patients. Methods: We searched all randomized controlled and cohort studies published by PubMed, EMBASE, and Cochrane Library from the inception to August 2022 on the prognostic impact of epinephrine on patients with OHCA. Survival to discharge was the primary outcome, while the return of spontaneous circulation (ROSC) and favorable neurological outcome were secondary outcomes. Results: The meta-analysis included 18 studies involving 863,952 patients. OHCA patients with adrenaline had an observably improved chance of ROSC (RR 2.81; 95% CI 2.21–3.57; P = 0.001) in randomized controlled studies, but the difference in survival to discharge (RR 1.27; 95% CI 0.58–2.78; P = 0.55) and favorable neurological outcomes (RR 1.21; 95% CI 0.90–1.62; P = 0.21) between the two groups was not statistically significant. In cohort studies, the rate of ROSC (RR 1.62; 95% CI 1.14–2.30; P = 0.007) increased significantly with the adrenaline group, while survival to discharge (RR 0.73; 95% CI 0.55–0.98; P = 0.03) and favorable cerebral function (RR 0.42; 95% CI 0.30–0.58; P = 0.001) were lower than the non-adrenaline group. Conclusion: We found that both the randomized controlled trials (RCTs) and cohort studies showed that adrenaline increased ROSC in OHCA patients. However, they were unable to agree on a long-term prognosis. The cohort studies showed that adrenaline had an adverse effect on the long-term prognosis of OHCA patients (discharge survival rate and good neurological prognosis), but adrenaline had no adverse effect in the RCTs. In addition to the differences in research methods, there are also some potential confounding factors in the included studies. Therefore, more high-quality studies are needed to fully confirm the effect of adrenaline on the long-term results of OHCA.

27 July 2024 in BMC Emergency Medicine
Verified
Journal Article
Open access
PDF file
HZHong Zhong
Hong Zhong
ZYZhaohui Yin
Zhaohui Yin
YWYanze Wang
Yanze Wang
PSPei Shen
Pei Shen
GHGuoli He
Guoli He
MZmanhong zhou
manhong zhou
Compared to the conventional cardiopulmonary resuscitation (CCPR), potential benefits of extracorporeal cardiopulmonary resuscitation (ECPR) for patients with cardiac arrest (CA) are still controversial. We aimed to determine whether ECPR can improve the prognosis of CA patients compared with CCPR. We systematically searched PubMed, EMBASE, and Cochrane Library from database’s inception to July 2023 to identify randomized controlled trials (RCTs) or cohort studies that compared ECPR with CCPR in adults (aged ≥ 16 years) with out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA). This meta-analysis was performed using a random-effects model. Two researchers independently reviewed the relevance of the study, extracted data, and evaluated the quality of the included literature. The primary outcome was short-term (from hospital discharge to one month after cardiac arrest) and long-term (≥ 90 days after cardiac arrest) survival with favorable neurological status (defined as cerebral performance category scores 1 or 2). Secondary outcomes included survival at 1 months, 3–6 months, and 1 year after cardiac arrest. The meta-analysis included 3 RCTs and 14 cohort studies involving 167,728 patients. We found that ECPR can significantly improve good neurological prognosis (RR 1.82, 95%CI 1.42–2.34, I2 = 41%) and survival rate (RR 1.51, 95%CI 1.20–1.89, I2 = 62%). In addition, the results showed that ECPR had different effects on favorable neurological status in patients with OHCA (short-term: RR 1.50, 95%CI 0.98- 2.29, I2 = 55%; long-term: RR 1.95, 95% CI 1.06–3.59, I2 = 11%). However, ECPR had significantly better effects on neurological status than CCPR in patients with IHCA (short-term: RR 2.18, 95%CI 1.24- 3.81, I2 = 9%; long-term: RR 2.17, 95% CI 1.19–3.94, I2 = 0%). This meta-analysis indicated that ECPR had significantly better effects on good neurological prognosis and survival rate than CCPR, especially in patients with IHCA. However, more high-quality studies are needed to explore the role of ECPR in patients with OHCA.

1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
LGLiming Gong
Liming Gong
XWXiuxuan Wang
Xiuxuan Wang
SXShaohua Xu
Shaohua Xu
FLFutuan Liao
Futuan Liao
MZmanhong zhou
manhong zhou
Background/Aims. Paraquat is an effective herbicide used worldwide. Due to high lung toxicity and a lack of effective treatment, elevated morbidity and mortality occur after ingestion. Mesenchymal stem cells (MSCs) may be an option for repairing, remodeling, or regenerating lungs damaged by paraquat. Human amnion‐derived mesenchymal stem cells (hAD‐MSCs) have significant biological advantages including low immunogenicity and noninvasive acquisition for acute and chronic lung injury. In this study, the preclinical efficacy of hAD‐MSCs in treating paraquat‐induced acute lung injury and pulmonary fibrosis was investigated. Clinical cell therapy was replicated including the dose and timing of hAD‐MSC treatment. Methods. First, the purity of hAD‐MSCs was determined by morphological observation and FCM, and the effects on the survival of paraquat‐poisoned Sprague‐Dawley rats were observed. All rats were randomly divided into three groups, defined as the sham control group (n = 8), model group (n = 15), and hAD‐MSC‐transplanted group (n = 17). Pneumonocyte damage and inflammatory cell infiltration were investigated in the three groups of rats, untreated control, paraquat only, and paraquat+hAD‐MSC transplanted, using H&E staining. Fibrosis was investigated in three groups of rats using Masson’s trichrome staining and Sirius red staining. The profibrotic factor TGF‐β1, the composition of fibrotic collagen HYP, and the hAD‐MSC‐secreted immunosuppressive factor HLA‐G5 in serum were investigated in the three groups of rats using ELISA. Furthermore, the distribution of hAD‐MSCs was investigated in the three groups of rats using immunohistochemistry and hematoxylin staining. Results. The hAD‐MSCs exhibited typical hallmarks of MSCs, improved the state of being and survival of paraquat‐poisoned rats, reduced both lung injury and inflammation, and inhibited the progression of pulmonary fibrosis by decreasing the deposition of collagen and the secretion of both TGF‐β1 and HYP. The hAD‐MSCs could survive in damaged lungs and secreted appropriate amounts of HLA‐G5 into the serum. Conclusion. The obtained results indicate that hAD‐MSCs used to treat paraquat‐induced lung injury may work through anti‐inflammatory and immunosuppressive pathways and the downregulation of profibrotic elements. This study suggests that the transplantation of hAD‐MSCs is a promising therapeutic approach for the treatment of paraquat‐intoxicated patients.